Exact Sciences Corporation (EXAS) — Analyst outlook / Analyst consensus target is. Based on 41 analyst ratings, the consensus is bullish — 22 Buy, 17 Hold, 2 Sell.
The consensus price target is $103.18 (low: $85.00, high: $105.00), representing a downside of 1.6% from the current price $104.91.
Analysts estimate Earnings Per Share (EPS) of $-1.16 and revenue of $2.75B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-5.59 vs est $-1.16 (missed -382.9%). 2025: actual $-1.10 vs est $-0.70 (missed -57.5%). Analyst accuracy: 42%.
EXAS Stock — 12-Month Price Forecast
$103.18
▼ -1.65% Downside
Average Price Target
Based on 41 Wall Street analysts offering 12-month price targets for Exact Sciences Corporation, the average price target is $103.18, with a high forecast of $105.00, and a low forecast of $85.00.
The average price target represents a -1.65% change from the last price of $104.91.
Highest Price Target
$105.00
Average Price Target
$103.18
Lowest Price Target
$85.00
EXAS Analyst Ratings
Buy
Based on 41 analysts giving stock ratings to Exact Sciences Corporation in the past 3 months
EPS Estimates — EXAS
42%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$5.59
vs Est –$1.16
▼ 79.3% off
2025
Actual –$1.10
vs Est –$0.70
▼ 36.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — EXAS
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $2.759B
vs Est $2.747B
▲ 0.4% off
2025
Actual $3.247B
vs Est $3.229B
▲ 0.5% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
